Michael Albrecht Nauck - Dissemin

Language
Login

All papers authored by Michael Albrecht Nauck

This paper was not found in any repository, but could be made available legally by the author.

2020 Shweta Urva

ORCID

, Tamer Coskun, Corina Loghin, Xuewei Cui, Emily Beebe, Libbey O'Farrell, Daniel A. Briere, Charles Benson, Michael A. Nauck

ORCID

ORCID

The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 ( GLP ‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP ‐1 receptor agonists

Upload

This paper is made freely available by the publisher.

Anna R. Kahkoska

ORCID

, Milan S. Geybels, Klara R. Klein, Frederik F. Kreiner, Nikolaus Marx, Michael A. Nauck

ORCID

, Richard E. Pratley, Benjamin O. Wolthers, John B. Buse

ORCID

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE , LEADER and SUSTAIN ‐6 cardiovascular outcomes trials

Download from api.wiley.com

This paper is made freely available by the publisher.

2018 Stephen C. Bain

ORCID

, Ofri Mosenzon, Rosario Arechavaleta, Pawel Bogdański, Abdurrahman Comlekci, Agostino Consoli, Chaicharn Deerochanawong, Kathleen Dungan

ORCID

, Maria C. Faingold, Michael E. Farkouh, Denise R. Franco, Jeppe Gram, Cristian Guja

ORCID

, Pankaj Joshi, Rachid Malek and 11 other authors

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.